.START 

Jon S. Saxe, 53 years old, was named president and chief executive officer of this pharmaceuticals and animal health products company, succeeding Larry Soll, 47, a founder of the company who will remain as chairman and continue an active role in the company.
Mr. Saxe, who is currently vice president, licensing and corporate development, at Hoffmann-La Roche Inc., was also elected to the board, increasing the board's size to eight. 

